Cannalink, Inc. (SUPI: OTC Pink No Information) | Splits
Top 10 Most Recent News Articles
American Tire Distributors Shifts Gears in Leadership
Another Day, Another Leadership Shuffle at ATD Well, the wheel's turning again at American Tire Distributors (ATD). The crew in Huntersville, N.C., just put Michael Broderick in the driver's seat as Interim President, replacing Ira B. Silver. And they've parted ways with him—done and dusted. This isn't just some random pick; Broderick's been kickin' around ATD's Board...
Continue Reading
Meitav Tops 2025 Service Index with Stellar Growth
Meitav’s Leap to The Summit Damn, it's a wild market when a pension fund provider snatches the crown. But here we are, looking at Meitav Provident Funds and Pension Ltd., standing proudly as Israel's top dog in the 2025 Service Index for pension funds. We're talking a jump from fourth to numero uno, folks, with a hefty score of 83 out of 100. And don't sleep on their...
Continue Reading
Ademi LLP Investigates Braze Buyout Concerns for Investors
Scrutinizing Braze's $5.66 Billion Salesforce Deal There's a shake-up brewing in the world of tech buyouts, and it's hitting home with Braze, Inc. (NASDAQ: BRZE). On the surface, a $47.50 per share all-cash offer from Salesforce might look like a shiny deal, totalling up to a robust $5.66 billion valuation. However, Ademi LLP, a law firm no stranger to corporate scrutiny,...
Continue Reading
Winter Prep: Home Safety Vital for Older Adults
Cold Weather is All About Precaution It ain't the first day at the fair when you realize winter's sneaking up, and with it, the looming concern of older family members hunkering down indoors. Executive Home Care's calling out, saying it straight: if you've got seniors in your midst, now's the time to batten down the hatches. The winter months can turn into a slippery...
Continue Reading
Aduna's New APIs: Combatting Fraud with Big Players
Aduna's Transformative Move Every so often, a partnership pops up and smashes through the fog in the tech world like a diamond in the rough. For Aduna, hooking up with titans like AT&T, T-Mobile, and Verizon ain't just another Tuesday. They've got sights set on delivering three potent fraud-fighting APIs that'll hit the market come Q4. And for any business manager who's...
Continue Reading
Sophont's Holon-S1: Revolutionizing Pathology and AI
Pushing Boundaries in Tumor Analysis with AI In the world of medical AI, it's not every day you hear about a tool that claims to read the secrets hidden within routine pathology slides to predict tumor behavior. Yet, here we are with Sophont's latest brainchild, the Holon-S1. This thing is more than just another AI model; it's a giant leap towards pulling the veil off...
Continue Reading
FAA Greenlights Boeing’s 737-10: What’s at Stake?
Breaking New Ground: Boeing 737-10 Certified Well, the folks at Boeing must be popping champagne, because the U.S. Federal Aviation Administration (FAA) just handed them the golden ticket: certification for the brand spankin' new Boeing 737-10. This ain't your average paper-pushing approval. We're talking nearly 1,000 test flights and what seems like a mountain of safety...
Continue Reading
Legal Heavyweight Joins Norris McLaughlin, Strengthens Team
Veteran Attorney Joins the Allentown Office Buckle up, folks—there's a new legal heavyweight in town. David "Neil" Hittinger's move to Norris McLaughlin, P.A. is like adding an ace to an already stacked deck. Sure, it's not every day a law firm catches the eye, but when Hittinger, with his impressive portfolio, strides into the Allentown office, it makes waves. The firm...
Continue Reading
Suunto Unleashes High-Tech Race 3S Watch with AI Coach
The Latest in Performance Gear: Suunto's Race 3S Nobody wants their gear to be a limitation, especially out in the wild where every step counts. Enter Suunto's Race 3S—a watch that looks to change the game for those passionate about trail running. This gadget's packed with features meant for athletes who are serious about their tech, yet light enough to make you forget...
Continue Reading
Triller's Tangle: Investors Face Massive Stock Drop
A Descent into Legal Quagmire Investor action notices usually scream trouble, and this time it’s Triller Group Inc. (NASDAQ: ILLR) taking the brunt. If you haven’t been under a rock, you’ve heard they’re in a spot of bother, courtesy of a gnarly combination of financial mishaps and misleading statements. It’s a classic case of a company shooting itself in the...
Continue ReadingTop 5 Most Recently Viewed Articles
Rancho Mission Viejo: Leading the Way in Wellness Real Estate
Rancho Mission Viejo Recognized Globally for Wellness Development The Ranch stands out as a model for wellness communities and showcases the impact on individual lives. This 23,000-acre master-planned community and functional cattle ranch has achieved global recognition as one of the largest intentional wellness real estate developments. A Testament to Community Design As...
Continue Reading
Revolutionizing Patient Access with AI: The New Trial Finder
Introducing the Future of Clinical Trials The world of radiopharmaceuticals is changing rapidly, with an innovative new tool set to revolutionize the way patients and healthcare providers access critical information about clinical trials. The Radiopharmaceutical Trial Finder, backed by the ICPO Foundation, was developed through a collaboration between WARMTH and...
Continue Reading
Semler Scientific Faces Legal Challenges Amid Controversy
Semler Scientific Under Legal Scrutiny Semler Scientific, Inc. is currently facing a class action lawsuit that sheds light on serious allegations regarding their securities practices. Shareholders of the company, identified by the ticker SMLR, are encouraged to be proactive amidst these developments. The lawsuit primarily alleges violations of federal securities exchanges...
Continue Reading
Charles Dayoub Joins The Willis Law Group Fraud Team
Charles Dayoub Enhances The Willis Law Group’s Fraud Team We are delighted to announce that Charles Dayoub has joined The Willis Law Group P.L.L.C., bringing with him a wealth of experience with over 18 years in law and extensive expertise in executive positions. His previous role at a prominent law firm involved dealing with government receivables and regulatory...
Continue Reading
Evaluating Revolution Medicines' Future Potential and Progress
Revolution Medicines Maintains Positive Outlook Piper Sandler has sustained an optimistic outlook regarding Revolution Medicines (NASDAQ: RVMD), reaffirming its Overweight rating with a specified price target of $57.00. This commitment to the stock's rating comes after recent developments linked to the company’s Phase I trial, which is focused on RMC-6236, a potential...
Continue Reading